Cutting-edge bio-new drug Ekonin ® (injecting With Abervet) gets CFDA approval for listing

AIDS is a major infectious disease in the field of public health, mainly through sexual transmissionThe number of infections in our country is still increasing, and the treatment of AIDSdrugs(the lack of varieties, there is a need to meet the major clinical needstoday,("Frontier Bio" ) Company, a
limited share of Frontier Biopharmaceuticals (Nanjing), announced that its independent research and development of a national class ofnew drugs(Akening ® (injecting with Abowetai) has been approved by the StatePharmaceutical(the Supervisory Authority) for listingon The ai cornin ®
Akening ® is the world's first long-acting HIV-1 fusion inhibitor, China's first original anti-AI drug, developed successfully by cutting-edge biological research and development, with global intellectual property rightsAkening ® is a new long-acting HIV-1 fusion inhibitor, approved by the State Administration of Drug Administration for "use with other antiretroviral drugs in combination with antiviral drugs to treat HIV-1 infections who are still infected with the virus after antiretroviral drugs."Clinical Phase IIItrial(interim data show that weekly injections of Acornin ® combined with Lopinavir/Litonavir (two drug combinations, trial group) to treat "first-line formula treatment of failed HIV-1 infections", the efficacy of the World Health Organization (WHO) recommended second-line formulation (three-drug combination, control group) is comparable or better Compared to the control group containing tinofovwe, the statistically better kidney safety was shown Akening ® has a new molecular mechanism, the epidemic of HIV-1 virus and drug-resistant virus are effective, and has a low frequency of drug use (once a week), high resistance barrier, high safety, small side effects and other unique advantages, can significantly improve patients' dependence on medication, improve the quality of life